J9集团官网

      Global
      关于J9集团官网

      致力于纳米抗体创新药物研发

      关于J9集团官网
      科研论文
      截止现在，J9集团官网生物研发团队在具有重要影响力的期刊上发表研究论文多篇。
      2022-06-08
      Nanobody-based label-free photoelectrochemical immunoassay for highly sensitive detection of SARS-CoV-2 spike protein
      发表于:Analytica chimica acta. 2022 Jun 8;1211:339904
      查看更多内容
      2022-01-11
      Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECTCT
      发表于:European Journal of Nuclear Medicine and Molecular Imaging. 2022 May;49(6):1810-1821
      查看更多内容
      2021-01-31
      A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential
      发表于:MedComm (2020). 2021 Mar;2(1):101-113
      查看更多内容
      2020-10-16
      Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy
      发表于:Journal for ImmunoTherapy of Cancer. 2020 Nov;8(2):e001156
      查看更多内容
      2020-10-15
      A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade
      发表于:Biochemical and Biophysical Research Communications. 2020 Oct 15;531(2):144-151
      查看更多内容
      2020-02-15
      Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model
      发表于:Bioorganic & Medicinal Chemistry Letters. 2020 Feb 15;30(4):126915
      查看更多内容
      总计 24 1234